PD-L1 expression in non-clear cell renal cell carcinoma.

被引：3
|
作者：
Fay, Andre P.
Callea, Marcella
Gray, Kathryn P.
Thai Huu Ho
Song, Jiaxi
Carvo, Ingrid
Lampron, Megan E.
Stanton, Melissa L.
McDermott, David F.
Atkins, Michael B.
Freeman, Gordon J.
Hirsch, Michelle S.
Signoretti, Sabina
Choueiri, Toni K.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Mayo Clin, Scottsdale, AZ USA
[4] Mayo Clin, Phoenix, AZ USA
[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[6] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[7] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[8] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.424
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
424
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PD-L1 expression in non-clear cell renal cell carcinoma and benign kidney tumors.
    Fay, Andre Poisl
    Callea, Marcella
    Gray, Kathryn P.
    Ho, Thai Huu
    Song, Jiaxi
    Carvo, Ingrid
    Lampron, Megan E.
    Albiges, Laurence
    Stanton, Melissa L.
    McDermott, David F.
    Atkins, Michael B.
    Freeman, Gordon James
    Hirsch, Michelle S.
    Signoretti, Sabina
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] PD-L1 expression in different non-clear cell renal cell carcinoma subtypes: an analysis of the SUNNIFORECAST cohort
    Ahrens, M.
    Vorfelder, L.
    Stoehr, C.
    Haanen, J.
    Escudier, B.
    Goupil, Gross M.
    Boleti, E.
    Gravis, G.
    Grimm, M. -O
    Negrier, S.
    Bedtke, J.
    Barthelemy, P.
    Castellano, D.
    Mellado, B.
    Ivanyi, P.
    Rottey, S.
    Floercken, A.
    Maroto, J. P.
    Suarez Rodriguez, C.
    Oosting, S.
    Panic, A.
    Hartmann, A.
    Bergmann, L.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 77 - 78
  • [3] Association between PD-L1 Expression and the Prognosis and Clinicopathologic Features of Non-Clear Cell Renal Cell Carcinoma
    Chrabanska, Magdalena
    Szweda-Gandor, Nikola
    Rynkiewicz, Magdalena
    Hrabos, Dominik
    Drozdzowska, Bogna
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [4] The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma
    McKay, Rana R.
    Bosse, Dominick
    Xie, Wanling
    Wankowicz, Stephanie A. M.
    Flaifel, Abdallah
    Brandao, Raphael
    Lalani, Aly-Khan A.
    Martini, Dylan J.
    Wei, Xiao X.
    Braun, David A.
    Van Allen, Eliezer
    Castellano, Daniel
    De Velasco, Guillermo
    Wells, J. Connor
    Heng, Daniel Y.
    Fay, Andre P.
    Schutz, Fabio A.
    Hsu, JoAnn
    Pal, Sumanta K.
    Lee, Jae Lyun
    Hsieh, James J.
    Harshman, Lauren C.
    Signoretti, Sabina
    Motzer, Robert J.
    Feldman, Darren
    Choueiri, Toni K.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2018, 6 (07) : 758 - 765
  • [5] The genomic landscape of metastatic non-clear cell renal cell carcinoma.
    Carlo, Maria Isabel
    Khan, Nabeela
    Chen, Yingbei
    Hsieh, James
    Hakimi, A. Ari
    Lee, Chung-Han
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [6] The survival benefit of metastasectomy for metastatic non-clear cell renal cell carcinoma.
    Dai, Jindong
    Hu, Xu
    Zhang, Haoran
    Zhang, Yaowen
    Zhang, Xingming
    Sun, Guangxi
    Zeng, Hao
    Shen, Pengfei
    Liu, Zhenhua
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [7] Relation between clinicopathological findings and PD-1 or PD-L1 status in non-clear cell renal cell carcinoma by a multicenter study.
    Matsumoto, Hiroaki
    Nagao, Kazuhiro
    Samoto, Masahiro
    Mori, Junichi
    Shimizu, Kosuke
    Inoue, Ryo
    Yamamoto, Yoshiaki
    Yano, Seiji
    Hirata, Hiroshi
    Shimabukuro, Tomoyuki
    Matsuyama, Hideyasu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [8] Non-Clear Cell Renal Cell Carcinoma
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (01) : 8 - 10
  • [9] Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma?
    Abbas, Mahmoud
    Steffens, Sandra
    Bellut, Maria
    Becker, Jan U.
    Grosshennig, Anika
    Eggers, Hendrik
    Wegener, Gerd
    Kuczyk, Markus A.
    Kreipe, Hans H.
    Gruenwald, Viktor
    Schrader, Andres J.
    Ivanyi, Philipp
    [J]. MEDICAL ONCOLOGY, 2016, 33 (06)
  • [10] Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma?
    Mahmoud Abbas
    Sandra Steffens
    Maria Bellut
    Jan U. Becker
    Anika Großhennig
    Hendrik Eggers
    Gerd Wegener
    Markus A. Kuczyk
    Hans H. Kreipe
    Viktor Grünwald
    Andres J. Schrader
    Philipp Ivanyi
    [J]. Medical Oncology, 2016, 33
12345